logo

Gilead Sciences Inc. (GILD)



Trade GILD now with
  Date
  Headline
3/1/2022 8:36:27 AM Gilead Gets Complete Response Letter From FDA For Investigational Lenacapavir Due To Vial Compatability Issues
2/11/2022 8:07:27 AM Gilead Says Remdesivir Retains Antiviral Activity Against Omicron, Delta And Other SARS-CoV-2 Variants In Studies
2/1/2022 4:40:36 PM Gilead Sciences Q4 EPS $0.30 Vs. $1.23 Year Ago
2/1/2022 4:26:29 PM Gilead Sciences Inc. (GILD) Declares $ 0.73 Dividend for Q1 22, Record Date 3/15/2022
1/31/2022 9:04:03 AM Gilead : FDA Approves New Label Update For CAR T-Cell Therapy Yescarta
1/25/2022 8:19:54 PM Gilead Announces Partial Clinical Hold For Studies Evaluating Magrolimab In Combination With Azacitidine
1/10/2022 8:42:36 AM Gilead, Merck To Evaluate Trodelvy In Combination With KEYTRUDA In First-Line Metastatic Non-Small Cell Lung Cancer
12/23/2021 6:27:47 AM Top 10 Blockbuster Drugs In 2021